OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Cheng‐Jian Xu, Kerstin Port, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 7, pp. 597-606
Open Access | Times Cited: 13

Showing 13 citing articles:

EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129

Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
Christopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100686-100686
Open Access | Times Cited: 43

Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series
Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Hepatology (2024) Vol. 80, Iss. 3, pp. 664-673
Open Access | Times Cited: 11

No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Julius Hollnberger, Yang Liu, Simin Xu, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 657-665
Closed Access | Times Cited: 18

Dynamics of Virological and Clinical Response Parameters of Bulevirtide Treatment for Hepatitis D: Real-World Data
Alexander Killer, Smaranda Gliga, Carolin Lohr, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 3, pp. 353-360
Open Access | Times Cited: 3

Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide
Pierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 819-826
Closed Access | Times Cited: 3

“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy
Ubaldo Visco‐Comandini, Emanuela De Santis, Francesco De Maria, et al.
HIV Medicine (2023) Vol. 24, Iss. 10, pp. 1075-1082
Open Access | Times Cited: 8

Advances in hepatitis delta research: emerging insights and future directions
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Sexually Transmitted Infections (2024) Vol. 100, Iss. 5, pp. 310-317
Closed Access

Hepatitis B and D virus entry
Koichi Watashi, Kaho Shionoya, Chisa Kobayashi, et al.
Nature Reviews Microbiology (2024)
Closed Access

Hepatitis Delta: Ready for primetime?
Benjamin Maasoumy, Pietro Lampertico
Liver International (2023) Vol. 43, Iss. S1, pp. 1-4
Open Access

Page 1

Scroll to top